Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Ascent CEO Colin Hutchinson with latest on review and permitting Watch Here

EXCLUSIVE: Ascent CEO Colin Hutchinson with latest on review and permitting


Faron Pharma Share Price (FARN)



Share Price Information for Faron Pharma (FARN)


Share Price: 116.50Bid: 115.00Ask: 118.00Change: 5.00 (+4.48%)Riser - Faron Pharma
Spread: 3.00Spread as %: 2.61%Open: 109.50High: 123.00Low: 109.50Yesterday’s Close: 111.50

Faron Pharmaceuticals Oy Ord Npv (Di)

Faron Pharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
116.50
Share Price SpacerBid
115.00
Share Price SpacerAsk
118.00
Share Price SpacerChange
4.48%5.00
Share Price SpacerVolume
172,349
Share Price SpacerOpen
109.50
Share Price SpacerHigh
123.00
Share Price SpacerLow
109.50
Share Price SpacerClose
111.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 30.09m £35.06m 500

52 Week High 890.00 52 Week High Date 28-FEB-2018
52 Week Low 55.00 52 Week Low Date 19-JUN-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
94 63,000 108,849 -1.725 -67.53 0.00 0.00


London South East Users info for Faron Pharma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

16-Aug-18
16:11:30
117.1001
88
Buy* 
115.00
118.00
103.05
Trade Type:
Ordinary

16-Aug-18
15:59:35
117.10
1,637
Buy* 
115.00
118.00
1,917
Trade Type:
Ordinary

16-Aug-18
15:47:25
117.00
860
Buy* 
115.00
118.00
1,006
Trade Type:
Ordinary




View more Faron Pharma trades >>

Directors Deals for Faron Pharma (FARN)
Trade DateActionNotifierPriceCurrencyAmountHolding
20-Jun-18Buy
Trade Notifier Information for Faron Pharmaceuticals Oy (DI)
Frank Armstrong held the position of Non-Executive Chairman at Faron Pharmaceuticals Oy (DI) at the time of this trade.
 Frank Armstrong
75GBX13,30022396
11-Oct-17Buy
Trade Notifier Information for Faron Pharmaceuticals Oy (DI)
Frank Armstrong held the position of Non-Executive Chairman at Faron Pharmaceuticals Oy (DI) at the time of this trade.
 Frank Armstrong
800GBX1,2509096
08-Sep-17Buy
Trade Notifier Information for Faron Pharmaceuticals Oy (DI)
Jonathan Knowles held the position of Non-Executive Director at Faron Pharmaceuticals Oy (DI) at the time of this trade.
 Jonathan Knowles
725GBX63,000110712
View more Faron Pharma directors dealings >>


Pommy1972
Posts: 101
Opinion:No Opinion
Price:116.50
RE: Re steady
Today 18:15
Hi Miss,

No that wouldn't be greedy, I'd call it a great end to the week, and one week closer to the end game which is what we want after all. ;¬)
Manifesto
Posts: 834
Opinion:No Opinion
Price:116.50
RE: Re steady
Today 18:10
Hi Pommy

Would it be greedy to want 20% tomorrow!!...LOL!
Plenty of interest in Pharma stocks at the moment!

Have a good evening!

GLA!
nomlungu
Posts: 1,662
Opinion:No Opinion
Price:116.50
Welsh, Carson, Anderson & Stowe
Today 18:02
The offer to buy ABZA was from WCAS - they own 100 percent of the newly incorporated Astro Bidco Limited.

https://www.wcas.com/firm/history
Pommy1972
Posts: 101
Opinion:No Opinion
Price:116.50
RE: Re steady
Today 18:00
I agree, hopefully the interest keeps up until some good news.

Have a good evening Miss M / Pred, same again tomorrow.
Manifesto
Posts: 834
Opinion:No Opinion
Price:116.50
RE: Re steady
Today 17:57
Agreed Pred!

Have a good evening!

I think the Japan trial results are keeping
the interest up here, and Astro buying out
Abzena today, has also sparked interest!
View more share chat for Faron Pharma (FARN) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.